Moxifloxacin ophthalmic solution recall due to assay out of trend
Summary
Health Canada issued a Type II recall for pms-MOXIFLOXACIN HCL 0.5% Ophthalmic Solution (DIN 02432218, Lot 240518) distributed nationally by Pharmascience. The recall was triggered because the assay is out of trend for the affected lot. Healthcare providers and consumers should verify if they have the affected product and consult with healthcare professionals before discontinuing use.
What changed
Health Canada has issued a Type II health product recall for a specific lot of pms-MOXIFLOXACIN ophthalmic solution (Lot 240518, DIN 02432218) manufactured by Pharmascience of Montreal, QC. The recall, identified as RA-81811, was triggered when testing revealed the assay is out of trend for this lot—a quality concern indicating the product's active ingredient concentration may not meet specifications. The recall depth extends to wholesalers and retailers nationwide.
Healthcare providers and patients should immediately verify whether they possess the affected lot 240518 of pms-MOXIFLOXACIN. The recall notice advises consulting a healthcare provider before discontinuing use of any affected product. Pharmascience should be contacted directly with questions, and any adverse reactions or health product safety complaints must be reported to Health Canada through the MedEffect Canada system. No specific compliance deadline was stated in the recall notice.
What to do next
- Verify if your pharmacy or healthcare facility has Lot 240518 of pms-MOXIFLOXACIN HCL 0.5% Ophthalmic Solution (DIN 02432218) in inventory
- Advise patients to consult their healthcare provider before discontinuing use of any affected product
- Report any adverse reactions or quality concerns related to this product to Health Canada via MedEffect Canada
Source document (simplified)
Health product recall
Moxifloxacin : assay out of trend
Brand(s)
Last updated
2026-03-30
Summary
Product pms-MOXIFLOXACIN HCL 0.5% LIQ 3 mL Issue Health products - Product quality What to do Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Distribution National
Affected products
| Product Name | Market Authorization | Dosage Form | Strength | Lot number |
| --- | --- | --- | --- | --- |
| pms-MOXIFLOXACIN | DIN 02432218 | Ophthalmic solution | MOXIFLOXACIN HYDROCHLORIDE 0.5% | 240518 |
Issue
The assay is out of trend in the affected lot.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of Recall: Wholesalers & Retailers
Details
Original published date:
2026-03-30
Alert / recall type Health product recall Category Health products - Drugs Companies Pharmascience
6111 avenue Royalmount, suite 100
Montréal QC
H4P 2T4
Published by Health Canada Audience General public Healthcare Industry Distribution National Recall class Type II Recall date
2026-03-26
Identification number RA-81811
Get notified
Receive emails about new and updated recall and safety alerts.
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when Health Canada Recalls & Safety Alerts publishes new changes.